Grantham, Mayo, Van Otterloo & Co (GMO)
HCA icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s HCA Healthcare HCA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,600
Closed -$1.58M – 733
2022
Q4 		$1.58M Sell
6,600
-6,600
-50% -$1.48M 0.01% 461
2022
Q3 		$2.43M Buy
13,200
+2,600
+25% +$518K 0.01% 401
2022
Q2 		$1.78M Buy
+10,600
New +$2.28M 0.01% 455
2021
Q2 		– Sell
-5,360
Closed -$1.01M – 779
2021
Q1 		$1.01M Sell
5,360
-6,600
-55% -$1.16M 0.01% 595
2020
Q4 		$1.97M Sell
11,960
-1,000
-8% -$146K 0.01% 444
2020
Q3 		$1.62M Sell
12,960
-700
-5% -$86.6K 0.01% 445
2020
Q2 		$1.33M Sell
13,660
-6,600
-33% -$686K 0.01% 488
2020
Q1 		$1.82M Buy
+20,260
New +$2.62M 0.02% 398
2019
Q4 		– Sell
-16,205
Closed -$1.95M – 719
2019
Q3 		$1.95M Sell
16,205
-32,995
-67% -$4.26M 0.01% 436
2019
Q2 		$6.65M Sell
49,200
-85,300
-63% -$10.8M 0.05% 240
2019
Q1 		$17.5M Sell
134,500
-3,200
-2% -$430K 0.13% 124
2018
Q4 		$17.1M Buy
+137,700
New +$18.5M 0.14% 106
2017
Q4 		– Sell
-3,400
Closed -$271K – 601
2017
Q3 		$271K Sell
3,400
-140,220
-98% -$11.3M ﹤0.01% 492
2017
Q2 		$12.5M Buy
143,620
+40,900
+40% +$3.46M 0.07% 163
2017
Q1 		$9.14M Buy
102,720
+55,320
+117% +$4.61M 0.05% 184
2016
Q4 		$3.51M Buy
47,400
+43,000
+977% +$3.22M 0.02% 265
2016
Q3 		$333K Buy
4,400
+500
+13% +$38.3K ﹤0.01% 424
2016
Q2 		$300K Sell
3,900
-1,600
-29% -$126K ﹤0.01% 516
2016
Q1 		$429K Buy
+5,500
New +$384K ﹤0.01% 477
2014
Q2 		– Sell
-44,100
Closed -$2.31M – 524
2014
Q1 		$2.31M Sell
44,100
-71,413
-62% -$3.55M 0.01% 397
2013
Q4 		$5.51M Sell
115,513
-18,538
-14% -$857K 0.01% 294
2013
Q3 		$5.73M Sell
134,051
-27,215
-17% -$1.06M 0.02% 288
2013
Q2 		$5.82M Buy
+161,266
New +$6.24M 0.02% 278

Other funds holding HCA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HCA Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 6,600 shares — an estimated $1.58M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HCA in Q2 2013 and held it in 23 quarters. The position peaked at $17.5M in Q1 2019. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 6,600 HCA Healthcare shares in Q1 2023, an estimated $1.58M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HCA Healthcare in Q2 2013 and held it in 23 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s HCA Healthcare position peaked at $17.5M in Q1 2019.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.